Clinical trial
Prospective Randomized Study Evaluating the Efficacy of the Spherical Absorptive Carbon AST-120 in Hemodialysis Patients With Uremic Pruritus..
NCT04639674 is registered in ClinicalTrials.gov with Conmed Pharmaceutical & Bio-Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Study Evaluating the Efficacy of the Spherical Absorptive Carbon AST-120 in Hemodialysis Patients With Uremic Pruritus..
- Lead sponsor
- Conmed Pharmaceutical & Bio-Medical Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 2, 2020
- Completion date
- August 31, 2022
- Enrollment
- 100 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
uremic pruritus